{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T23:03:12Z","timestamp":1772665392845,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>This study aimed to use quantitative values, calculated from bone single photon emission computed tomography (SPECT) imaging, to estimate the reliability of progression evaluation for anti-resorptive agent-related osteonecrosis of the jaw (ARONJ).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study population consisted of 21 patients (23 lesions), clinically diagnosed with mandibular ARONJ, who underwent SPECT\/CT scanning. Diagnosis and staging of ARONJ were performed according to the American Association of Oral and Maxillofacial Surgeons (AAOMS) definition and the recommendations of the International Task Force on ONJ. Hybrid SPECT\/CT imaging quantitative analyses were performed on a workstation. Each volume of interest (VOI) was semi-automatically placed over a lesion with areas of high tracer accumulation, using the GI-BONE<jats:sup>\u00ae<\/jats:sup> software default threshold method settings. Additionally, control VOI was manually set over an unaffected area. Measured parameters included standardized uptake values (SUV)\u2014maximum (SUV<jats:sub>max<\/jats:sub>) and mean (SUV<jats:sub>mean<\/jats:sub>), metabolic bone volume (MBV)\u2014the total volume above the threshold, and total bone uptake (TBU) as calculated by MBV\u2009\u00d7\u2009SUV<jats:sub>mean<\/jats:sub>. We also calculated the SUV ratio (rSUV) between the lesion and control area, factoring for differences in individual bone metabolism; the ratios were termed rSUV<jats:sub>max<\/jats:sub> and rSUV<jats:sub>mean<\/jats:sub>, accordingly. The product of multiplying the rSUV<jats:sub>mean<\/jats:sub> by MBV of a lesion was defined as the ratio of TBU (rTBU). Quantitative values were compared between clinical stages by the Kruskal\u2013Wallis test and subsequent post hoc analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>MBVs (cm<jats:sup>3<\/jats:sup>) were: median, [IQR] Stage 1, 8.28 [5.62\u20139.49]; Stage 2, 15.28 [10.64\u201324.78]; and Stage 3, 34.61 [29.50\u201340.78]. MBV tended to increase with stage increase. Furthermore, only MBV showed a significant difference between clinical stages (<jats:italic>p\u2009<\/jats:italic>&lt;\u20090.01). Subsequent post hoc analysis showed no significant difference between stages 1 and 2 (<jats:italic>p\u2009<\/jats:italic>=\u20090.12) but a significant difference between stages 2 and 3 (<jats:italic>p\u2009<\/jats:italic>=\u20090.048). rSUVmax and rTBU tended to increase with stage increase, but the differences between the stages were not significant (<jats:italic>p<\/jats:italic>\u2009=\u20090.10 and <jats:italic>p<\/jats:italic>\u2009=\u20090.055, respectively).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>MBV, which includes the concept of volume, showed significant differences between clinical stages and tended to increase with the stage increase. As an objective and reliable indicator, MBV might be an adjunct diagnostic method for staging ARONJ.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12149-020-01485-4","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T17:05:52Z","timestamp":1592413552000},"page":"620-628","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Quantitative evaluation of anti-resorptive agent-related osteonecrosis of the jaw using bone single photon emission computed tomography in clinical settings: relationship between clinical stage and imaging"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9894-4936","authenticated-orcid":false,"given":"Taro","family":"Okui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Tsujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,15]]},"reference":[{"key":"1485_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.tripleo.2008.09.019","volume":"107","author":"F Wilde","year":"2009","unstructured":"Wilde F, Steinhoff K, Frerich B, Schulz T, Winter K, Hemprich A, et al. Positron-emission tomography imaging in the diagnosis of bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107:412\u20139.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"1485_CR2","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61:1115\u20137.","journal-title":"J Oral Maxillofac Surg"},{"key":"1485_CR3","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update. J Oral Maxillofac Surg. 2014;72:1938\u201356.","journal-title":"J Oral Maxillofac Surg"},{"key":"1485_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jbmr.2405","volume":"30","author":"AA Khan","year":"2015","unstructured":"Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O\u2019Ryan F, et al. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res. 2015;30:3\u201323.","journal-title":"J Bone Miner Res"},{"key":"1485_CR5","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s13139-012-0144-x","volume":"46","author":"CM Hong","year":"2012","unstructured":"Hong CM, Ahn BC, Choi SY, Kim DH, Lee SW, Kwon TG, et al. Implications of three-phase bone scintigraphy for the diagnosis of bisphosphonate-related osteonecrosis of the jaw. Nucl Med Mol Imaging. 2012;46:162\u20138.","journal-title":"Nucl Med Mol Imaging"},{"key":"1485_CR6","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.jcms.2015.06.025","volume":"43","author":"AT Assaf","year":"2015","unstructured":"Assaf AT, Zrnc TA, Remus CC, Adam G, Zustin J, Heiland M, et al. Intraindividual comparison of preoperative (99\u00a0m)Tc-MDP SPECT\/CT and intraoperative and histopathological findings in patients with bisphosphonate- or denosumab-related osteonecrosis of the jaw. J Craniomaxillofac Surg. 2015;43:1461\u20139.","journal-title":"J Craniomaxillofac Surg"},{"key":"1485_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12149-017-1224-x","volume":"32","author":"T Umeda","year":"2018","unstructured":"Umeda T, Koizumi M, Fukai S, Miyaji N, Motegi K, Nakazawa S, et al. Evaluation of bone metastatic burden by bone SPECT\/CT in metastatic prostate cancer patients: defining threshold value for total bone uptake and assessment in radium-223 treated patients. Ann Nucl Med. 2018;32:105\u201313.","journal-title":"Ann Nucl Med"},{"key":"1485_CR8","first-page":"2662","volume":"4","author":"AH Vija","year":"2003","unstructured":"Vija AH, Hawman EG, Engdahl JC. Analysis of a SPECT OSEM reconstruction method with 3D beam modeling and optional attenuation correction: phantom studies. IEEE Nucl Sci Symp Conf Rec. 2003;4:2662\u20136.","journal-title":"IEEE Nucl Sci Symp Conf Rec."},{"key":"1485_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/MNM.0000000000000854","volume":"39","author":"M Tsujimoto","year":"2018","unstructured":"Tsujimoto M, Shirakawa S, Teramoto A, Ishiguro M, Nakane K, Ida Y, et al. Fluctuation of quantitative values on acquisition time and the reconstruction conditions in 99mTc-SPECT. Nucl Med Commun. 2018;39:601\u20139.","journal-title":"Nucl Med Commun"},{"key":"1485_CR10","first-page":"776","volume":"33","author":"I Ogura","year":"2019","unstructured":"Ogura I, Kobayashi E, Nakahara K, Igarashi K, Haga-Tsujimura M, et al. Quantitative SPECT\/CT imaging for medication-related osteonecrosis of the jaw: a preliminary study using volume-based parameters, comparison with chronic osteomyelitis. Nucl Med Commun. 2019;33:776\u201382.","journal-title":"Nucl Med Commun"},{"key":"1485_CR11","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.joms.2015.10.025","volume":"74","author":"KE Fleisher","year":"2016","unstructured":"Fleisher KE, Pham S, Raad RA, Friedman KP, Ghesani M, Chan KC, et al. Does fluorodeoxyglucose positron emission tomography with computed tomography facilitate treatment of medication-related osteonecrosis of the jaw? J Oral Maxillofac Surg. 2016;74:945\u201358.","journal-title":"J Oral Maxillofac Surg"},{"key":"1485_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2967\/jnumed.107.048785","volume":"50","author":"F Dore","year":"2009","unstructured":"Dore F, Filippi L, Biasotto M, Chiandussi S, Cavalli F, Di Lenarda R. Bone scintigraphy and SPECT\/CT of bisphosphonate-induced osteonecrosis of the jaw. J Nucl Med. 2009;50:30\u20135.","journal-title":"J Nucl Med"},{"key":"1485_CR13","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/RCT.0b013e318186b179","volume":"33","author":"SB Gill","year":"2009","unstructured":"Gill SB, Valencia MP, Sabino ML, Heideman GM, Michel MA. Bisphosphonate-related osteonecrosis of the mandible and maxilla: clinical and imaging features. J Comput Assist Tomogr. 2009;33:449\u201354.","journal-title":"J Comput Assist Tomogr"},{"key":"1485_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00774-016-0810-7","volume":"35","author":"T Yoneda","year":"2017","unstructured":"Yoneda T, Hagino H, Sugimoto T, Ohta H, Takahashi S, Soen S, et al. Antiresorptive agent-related osteonecrosis of the jaw: position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw. J Bone Miner Metab. 2017;35:6\u201319.","journal-title":"J Bone Miner Metab"}],"updated-by":[{"DOI":"10.1007\/s12149-022-01755-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000}}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-020-01485-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-020-01485-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-020-01485-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T11:56:10Z","timestamp":1652874970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-020-01485-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,15]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["1485"],"URL":"https:\/\/doi.org\/10.1007\/s12149-020-01485-4","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12149-022-01755-3","asserted-by":"object"}]},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,15]]},"assertion":[{"value":"12 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12149-022-01755-3","URL":"https:\/\/doi.org\/10.1007\/s12149-022-01755-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}